The demonstration that TRPV2 is both strongly expressed in the VSMCs of human retinal arterioles and is downregulated in human diabetes suggests that similar pathophysiological processes may underpin the loss of the retinal myogenic response and pressure autoregulation in both experimental and human diabetes. This evidence concerns the gene TRPV2 and diabetes mellitus.